CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

Advancing Equity Through Precision Heart Care

Cleerly Episode Featured on the AHA's Advancing Health Podcast Series Dr. Leon D. Caldwell, Senior Director, Health Equity Strategies and Innovation, in the Institute of Diversity and Health Equity at the AHA, sits down with Dr. James Min, CEO and...

Read More »
Cleerly PAtient Testimonial - Terry Schemmel

3 min read

Cleerly Analysis Offers Critical Insight on Heart Health

Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care, emphasizing comprehensive...

Read More »
Cleerly PAtient Testimonial - Terry Schemmel

2 min read

When It's Good to Find Something Bad

For the last 50 years, cardiology care has focused on treating symptoms of heart disease, rather than its root cause - atherosclerosis. At Cleerly,...

Read More »

3 min read

New Staging System for Coronary Artery Disease

New research proposes a four-stage system for measuring the progression of cardiovascular disease (CAD) based on atherosclerotic plaque -...

Read More »

4 min read

How to Reduce Unnecessary, Invasive Procedures

Cleerly is excited to have released our vision statement calling for a new approach to cardiovascular care. It's an important topic - not just for...

Read More »

4 min read

Why Treating Symptoms Does Not Prevent Heart Attacks

Cleerly is excited to have released our vision statement calling for a new approach to cardiovascular care. It's an important topic - not just for...

Read More »

3 min read

Transforming Cardiac Care: A New Cleerly Webinar Series

There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.

Read More »

1 min read

Cleerly CEO Featured on AWS Health Innovation Podcast

Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.

Read More »
Cleerly's CLARIFY 2 study demonstrates the efficacy of its non-invasive AI-enabled CCTA approach for heart disease evaluation

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...

Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...

Read More »